Jordan Erica
SEC insider (Form 3/4/5 filer). CIK 0002012846. Chief Commercial Officer at Revance Therapeutics, Inc. (RVNC). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 6, 2025. Located in NASHVILLE, TN.
Companies Jordan Erica has filed insider reports for
- Revance Therapeutics, Inc. (RVNC): Officer, Chief Commercial Officer
Jordan Erica
CIK: 0002012846
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RVNC
Revance Therapeutics, Inc.
Officer